{"id":331660,"date":"2026-10-29T12:22:52","date_gmt":"2026-10-29T06:52:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=331660"},"modified":"2026-10-29T12:22:52","modified_gmt":"2026-10-29T06:52:52","slug":"contract-formulations-company-research-led-manufacturing-partner-and-global-generics-leader-stocks-roadmap-ember-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/contract-formulations-company-research-led-manufacturing-partner-and-global-generics-leader-stocks-roadmap-ember-list\/","title":{"rendered":"3 Contract Formulations Company, Research Led Manufacturing Partner and Global Generics Leader Stocks With a Strong Future Roadmap: Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories"},"content":{"rendered":"

Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories: ROE of 11.1% to 19.4% and FY22 to FY26 revenue CAGR of 12.3% to 19.5%. Prices as of 27 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three contract pharma, biosciences and generics stocks to watch are Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories. Their return on equity ranges from 11.1% to 19.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.3% to 19.5%. Anthem Biosciences has the highest return on equity at 19.4%, while Innova Captab has the fastest revenue growth at 19.5% a year. Prices are based on the 27 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Contract pharma, biosciences and generics stocks let investors follow companies that serve a growing part of the Indian economy. Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories cover a contract formulations company, a research led manufacturing partner and a global generics leader.<\/p>\n

This list covers three contract pharma, biosciences and generics stocks with complete current figures: Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories. Every figure comes from the latest reported financials and the 27 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n